Vaccination against COVID-19: a challenge in CLL

por Eichhorst, Barbara
Publicado 2021

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia

por Eichhorst, Barbara, Ghia, Paolo
Publicado 2020

Novel Agents in Chronic Lymphocytic Leukemia: New Combination Therapies and Strategies to Overcome Resistance

por Fürstenau, Moritz, Eichhorst, Barbara
Publicado 2021

Sequential and combination treatments with novel agents in chronic lymphocytic leukemia

por Fürstenau, Moritz, Hallek, Michael, Eichhorst, Barbara
Publicado 2019

72/m mit Zufallsbefund einer Lymphozytose: Vorbereitung auf die Facharztprüfung: Fall 34

por Langerbeins, Petra, Eichhorst, Barbara, Hallek, Michael
Publicado 2022

Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?

por Fürstenau, Moritz, De Silva, Nisha, Eichhorst, Barbara, Hallek, Michael
Publicado 2019

Invasive Aspergillosis in Patients Treated With Ibrutinib

por Fürstenau, Moritz, Simon, Florian, Cornely, Oliver A., Hicketier, Tillman, Eichhorst, Barbara, Hallek, Michael, Mellinghoff, Sibylle C.
Publicado 2020

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)

por Eichhorst, Barbara, Lamanna, Nicole, O’brien, Susan, Tam, Constantine, Qiu, Lugui, Yang, Keri, Wu, Ken, Salmi, Tommi, Barnes, Gisoo, Brown, Jennifer R.
Publicado 2023

COVID‐19 complicated by parainfluenza co‐infection in a patient with chronic lymphocytic leukemia

por Langerbeins, Petra, Fürstenau, Moritz, Gruell, Henning, Klein, Florian, Persigehl, Thorsten, Rybniker, Jan, Seeger‐Nukpezah, Tamina, Kochanek, Matthias, Hallek, Michael, Eichhorst, Barbara, Koehler, Philipp, Böll, Boris
Publicado 2020

Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group

por von Tresckow, Julia, Heyl, Nikola, Robrecht, Sandra, Giza, Adam, Aldaoud, Ali, Schlag, Rudolf, Klausmann, Martine, Linde, Hartmut, Stein, Wolfgang, Schwarzer, Andreas, Fischer, Kirsten, Cramer, Paula, Eichhorst, Barbara, Hallek, Michael, Fink, Anna Maria
Publicado 2023

Pembrolizumab in relapsed or refractory Richter syndrome

por Armand, Philippe, Murawski, Niels, Molin, Daniel, Zain, Jasmine, Eichhorst, Barbara, Gulbas, Zafer, Hawkes, Eliza A., Pagel, John M., Phillips, Tycel, Ribrag, Vincent, Svoboda, Jakub, Stathis, Anastasios, Chatterjee, Arkendu, Orlowski, Robert, Marinello, Patricia, Christian, Beth
Publicado 2020

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group

por Jaramillo, Sonia, Agathangelidis, Andreas, Schneider, Christof, Bahlo, Jasmin, Robrecht, Sandra, Tausch, Eugen, Bloehdorn, Johannes, Hoechstetter, Manuela, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, Hallek, Michael, Döhner, Hartmut, Rosenquist, Richard, Ghia, Paolo, Stamatopoulos, Kostas, Stilgenbauer, Stephan
Publicado 2019

CD20 Expression as a Possible Novel Prognostic Marker in CLL: Application of EuroFlow Standardization Technique and Normalization Procedures in Flow Cytometric Expression Analysis

por Schilhabel, Anke, Walter, Peter Jonas, Cramer, Paula, von Tresckow, Julia, Kohlscheen, Saskia, Szczepanowski, Monika, Laqua, Anna, Fischer, Kirsten, Eichhorst, Barbara, Böttcher, Sebastian, Schneider, Christof, Tausch, Eugen, Brüggemann, Monika, Kneba, Michael, Hallek, Michael, Ritgen, Matthias
Publicado 2022

The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab

por Kreuzer, Karl-Anton, Furman, Richard R., Stilgenbauer, Stephan, Dubowy, Ronald L., Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara, Hillmen, Peter, O’Brien, Susan M., Pettitt, Andrew R., Hallek, Michael
Publicado 2019

Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440)

por Stilgenbauer, Stephan, Morschhauser, Franck, Wendtner, Clemens-Martin, Cartron, Guillaume, Hallek, Michael, Eichhorst, Barbara, Kozloff, Mark F., Giever, Thomas, Lozanski, Gerard, Jiang, Yanwen, Huang, Huang, Pignataro, Daniela Soriano, Schary, William, Humphrey, Kathryn, Mobasher, Mehrdad, Salles, Gilles
Publicado 2020

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies

por Pflug, Natali, Chakupurakal, Geothy, Fink, Anna-Maria, Robrecht, Sandra, Herling, Marco, Cramer, Paula, Holtick, Udo, Theurich, Sebastian, Schetelig, Johannes, Fischer, Kirsten, Ritgen, Matthias, Scheid, Christof, Eichhorst, Barbara, Dreger, Peter, Hallek, Michael, von Bergwelt-Baildon, Michael
Publicado 2021

P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY PROFILE AND COMPARISON WITH IBRUTINIB PROFILE IN PATIENTS WITH B-CELL MALIGNANCIES: POST HOC ANALYSIS OF A LARGE CLINICAL...

por Brown, Jennifer R., Eichhorst, Barbara, Ghia, Paolo, Jurczak, Wojciech, Kahl, Brad, Lamanna, Nicole, Robak, Tadeusz, Shadman, Mazyar, Tam, Constantine, Qiu, Lugui, Cohen, Aileen, Zhang, Meng, Salmi, Tommi, Paik, Jason, Wang, Liping, Zhang, Jun, MA, Han, Tedeschi, Alessandra
Publicado 2023

SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia

por Mellinghoff, Sibylle C., Robrecht, Sandra, Mayer, Leonie, Weskamm, Leonie M., Dahlke, Christine, Gruell, Henning, Vanshylla, Kanika, Schlösser, Hans A., Thelen, Martin, Fink, Anna-Maria, Fischer, Kirsten, Klein, Florian, Addo, Marylyn M., Eichhorst, Barbara, Hallek, Michael, Langerbeins, Petra
Publicado 2021

SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia

por Mellinghoff, Sibylle C., Mayer, Leonie, Robrecht, Sandra, Weskamm, Leonie M., Dahlke, Christine, Gruell, Henning, Schlotz, Maike, Vanshylla, Kanika, Schlößer, Hans A., Thelen, Martin, Fink, AnnaMaria, Fischer, Kirsten, Klein, Florian, Addo, Marylyn M., Eichhorst, Barbara, Hallek, Michael, Langerbeins, Petra
Publicado 2022

Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial

por von Tresckow, Julia, Cramer, Paula, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Fürstenau, Moritz, Illmer, Thomas, Klaproth, Holger, Tausch, Eugen, Ritgen, Matthias, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Böttcher, Sebastian, Eichhorst, Barbara F., Hallek, Michael
Publicado 2022